A cross-sectional study of risk factors associated with sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease
BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver disease linked to several adverse health consequences that include metabolic disturbances affecting skeletal muscle. Sarcopenia, characterized by skeletal muscle loss, is commonly observed in individuals wi...
Saved in:
| Main Authors: | Johnny Amer, Qusay Abdoh, Zaina Salous, Eithar Abu Alsoud, Sama AbuBaker, Ahmad Salhab, Manal Badrasawi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1488068/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of Systemic Inflammatory Response Index and Prognostic Nutritional Index Scores with Sarcopenia in Patients with Metastatic Gastric Cancer
by: Busra Kanbur, et al.
Published: (2025-04-01) -
Comparison of sarcopenia screening indices using serum creatinine and cystatin C in metabolic dysfunction-associated steatotic liver disease
by: Inyoung Hwang, et al.
Published: (2025-08-01) -
The association of sarcopenia and frailty in diabetes‐related foot disease: A 3‐year prospective evaluation
by: Kay Yee Hon, et al.
Published: (2025-03-01) -
An Indian Consensus on Sarcopenia: Epidemiology, Etiology, Clinical Impact, Screening, and Therapeutic Approaches
by: Kalra S, et al.
Published: (2025-03-01) -
Predicting the occurrence of probable sarcopenia in middle-aged and elderly patients with coronary artery disease: development and validation of a clinical model
by: Xiaolan Sun, et al.
Published: (2025-08-01)